Filing Details

Accession Number:
0001104659-25-047089
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2025-05-12 09:25:24
Reporting Period:
2025-05-06
Filing Date:
2025-05-12
Accepted Time:
2025-05-12 09:25:24
Original Submission Date:
2025-05-09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1875558 Nuvectis Pharma Inc. NVCT () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1806384 Charles Marlio Mosseri 27 Ripplevale Grove
London N1 1HS
No No Yes No
Transaction Summary
Purchased: 27,662 shares Avg. Price: $8.94 Total Value: $247,263.02
Number of Shares After Transactions: 2,936,594 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-08 100 $8.99 2,909,032 No 4 P Indirect By Emerald Hill Ventures SARL SPF.
Common Stock Acquisiton 2025-05-08 100 $8.71 2,909,132 No 4 P Indirect By Emerald Hill Ventures SARL SPF.
Common Stock Acquisiton 2025-05-08 2,400 $8.97 2,911,532 No 4 P Indirect By Emerald Hill Ventures SARL SPF.
Common Stock Acquisiton 2025-05-09 9,850 $8.95 2,921,382 No 4 P Indirect By Emerald Hill Ventures SARL SPF.
Common Stock Acquisiton 2025-05-09 9,817 $8.90 2,931,199 No 4 P Indirect By Emerald Hill Ventures SARL SPF.
Common Stock Acquisiton 2025-05-09 5,395 $8.98 2,936,594 No 4 P Indirect By Emerald Hill Ventures SARL SPF.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Emerald Hill Ventures SARL SPF.
No 4 P Indirect By Emerald Hill Ventures SARL SPF.
No 4 P Indirect By Emerald Hill Ventures SARL SPF.
No 4 P Indirect By Emerald Hill Ventures SARL SPF.
No 4 P Indirect By Emerald Hill Ventures SARL SPF.
No 4 P Indirect By Emerald Hill Ventures SARL SPF.
Footnotes
  1. Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
  2. The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to correct the price of securities acquired by the reporting in the reported transactions.
  3. The original Form 4, filed on May 9, 2025, is being amended by this Form 4 amendment to include transactions that occurred on May 9, 2025.